whistleblower attorney

Healthpoint to Pay up to $48 Million for False Medicare and Medicaid Claims

Submitted by lhaveson on March 7, 2013
December 6, 2012

Healthpoint Ltd. and DFB Pharmaceuticals have agreed to pay up to $48 million to resolve allegations that Healthpoint caused false claims to be submitted to Medicare and Medicaid programs for a non-FDA approved skin ointment, Xenaderm.  The U.S. Department of Justice alleges that Healthpoint misrepresented Xenaderm’s regulatory status in its government reports and knowingly caused false claims to be submitted for the product.

The lawsuit was brought under the qui tam, or whistleblower, provisions of the False Claims Act, which allow private parties with knowledge of fraud to sue on behalf of the United States and share in any recovery.   This settlement is part of a series of recoveries totaling over $100 million from manufacturers of unapproved drugs.   The relator, or whistleblower, Ms. Constance Conrad, is eligible to recover 15% to 30% of the settlement, however, an agreement between the government and Ms. Conrand regarding her award has not been reached yet.

The Chanler Group, in association with the Hirst Law Group, represents whistleblowers who take action under the False Claims Act to report fraud committed against the federal and state governments.  We have years of experience representing whistleblower clients who uncover fraud of every kind perpetrated against our government including, health care fraud, contract fraud, and tax fraud.  Read more about our expertise in False Claims Act cases and how you can take action.

Cross-Post On: 
None

The Chanler Group Supports Project Open Hand

Submitted by T324Admin on February 16, 2013
December 13, 2012
Image: 

The Chanler Group's senior paralegal and nine of its attorneys attended Project Open Hand's 21st Annual Hand-to-Hand Luncheon, supporting its charitable mission of providing nutritious meals and groceries to people with symptomatic HIV/AIDS or breast cancer, homebound or critically ill people, and seniors in the San Francisco Bay Area. Chanler Group attorneys participated in a silent auction and made donations toward this worthy cause.  The Chanler Group is proud to be part of Project Open Hand's Brass Plate Club of donors, whose giving has totaled from $2,500 - $4,999 since October 2012.

Visit Project Open Hand's website to make a donation.

The Chanler Group represents citizen enforcers and whistleblowers who promote awareness of toxic chemicals found in our everyday environment and to enhance the health of the general public by advocating for the removal of chemicals known to cause cancer or reproductive harm from consumer products.  The Chanler Group and its clients apply over 20 years of knowledge and experience to their ongoing enforcement activities with the goal of holding those responsible for toxic exposures accountable for their violations of state and federal law.  

In the photo, from left to right: Larry Haveson, Brian Johnson, Rosalind Conrad, John Mayo, Rachel Doughty, Harris Weinstein, Josh Voorhees, Laralei Paras

Admin Notes: 
Is there a way to add a caption to the image? Consider embedding it within the entry so that a caption or alt-text can be added.
Cross-Post On: 
None

President Obama Issues Directive Protecting Intelligence Community Whistleblowers

Submitted by T324Admin on February 16, 2013
October 11, 2012

Yesterday, President Obama issued a Presidential Policy Directive to protect national security and intelligence community whistleblowers from retaliation for reporting violations law, gross waste or mismanagement, and abuse of authority, among other activities.

The Chanler Group, in association with the Hirst Law Group, represents whistleblowers who take action under the False Claims Act to report fraud committed against the federal and state governments.  We have years of experience representing whistleblower clients who uncover fraud of every kind perpetrated against our government including, health care fraud, contract fraud, and tax fraud.  Read more about our expertise in False Claims Act cases and how you can take action.

Cross-Post On: 
None

CVS Subsidiary Agrees to $5 Million Settlement with U.S. DOJ

Submitted by T324Admin on February 16, 2013
October 16, 2012

A CVS subsidiary, RxAmerica, has agreed to a $5 million settlement with the U.S. Department of Justice based on allegations that they defrauded the Medicare prescription drug plan.  RxAmerica allegedly received Medicare Part D payments for covered generic prescription medication at prices that were sometimes significantly higher than pricing data the company submitted to Medicare's web-based Plan Finder tool.  This not only cost the Medicare program money, but also allegedly caused beneficiaries losses when they entered a gap in their coverage (frequently referred to as the "donut hole") due to the price difference of their medication.  The two whistleblower plaintiffs in the case should be eligible for up to 30% of the settlement according to the qui tam provisions of the False Claims Act, but the press release from the Department of Justice did not specify the amount.

The Chanler Group, in association with the Hirst Law Group, represents whistleblowers who take action under the False Claims Act to report fraud committed against the federal and state governments.  We have years of experience representing whistleblower clients who uncover fraud of every kind perpetrated against our government including, health care fraud, contract fraud, and tax fraud.  Read more about our expertise in False Claims Act cases and how you can take action.

Cross-Post On: 
None
Syndicate content